Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Málaga
Clinical trial register · Spain

Clinical Trials in Málaga, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 113 Madrid 106 Seville 47 Valencia 38 L'Hospitalet de Llobregat 35
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca66 Janssen Research & Development, LLC30 Merck Sharp & Dohme LLC29 Hoffmann-La Roche28 Bristol-Myers Squibb26 Clear sponsor filter
Site location
Barcelona113 Madrid106 Seville47 Valencia38 L'Hospitalet de Llobregat35
All 70 locations
Target enrolment
to

Trials with a site in Málaga

29 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
960
Badalona, Málaga, Barcelona, Madrid, Salamanca
2026-06-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
L'Hospitalet de Llobregat, Barakaldo, Barcelona, Málaga, Badajoz, Madrid, Seville, Valencia
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Badalona, Málaga, Barcelona, Madrid
2026-05-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Las Palmas de Gran Canaria, Girona, Majadahonda, Barcelona, Madrid, Málaga, Seville
2026-03-18
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
570
Madrid, Valencia, Barcelona, Málaga
2025-12-18
Recruiting
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
NCT07222488Bladder Cancer, Urinary Bladder Neoplasms
DrugMK-3120
Merck Sharp & Dohme LLC
Phase 1/2
45
Málaga, Madrid
2025-12-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Málaga, Barcelona, Madrid
2025-12-04
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
605
L'Hospitalet de Llobregat, Majadhonda, Madrid, Valencia, Barcelona, Málaga
2025-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
L'Hospitalet de Llobregat, Barcelona, Madrid, Málaga
2025-03-25
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
327
Eixample, L'Hospitalet de Llobregat, Madrid, Barcelona, Málaga
2025-02-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
32
Málaga, Madrid
2024-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Canarias, A Coruña, Pozuelo de Alarcón, Barcelona, Madrid, Málaga
2024-10-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Málaga, Centelles, Barcelona, Figueres, A Coruña, Santiago de Compostela, Pozuelo de Alarcón, Alcorcón
2024-08-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Santiago de Compostela, Las Palmas de Gran Canaria, Málaga, Barcelona, Madrid, Seville
2024-06-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Las Palmas de Gran Canaria, Leganés, Madrid, Málaga, Barcelona, Seville
2024-05-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Badalona, L'Hospitalet Del Llobregat, Barcelona, Santiago de Compostela, Madrid, Marbella, Albacete, Málaga
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Sabadell, Barcelona, Girona, A Coruña, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Burgos, Málaga
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Jerez de la Frontera, A Coruña, Pozuelo de Alarcón, Málaga, Valencia, Barcelona, Madrid, Santa Cruz de Tenerife
2023-12-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
L'Hospitalet de Llobregat, Pozuelo de Alarcón, Majadahonda, Málaga, Barcelona, Seville
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Barcelona, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Madrid, Málaga
2023-11-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Torrevieja, Córdoba, Málaga, Seville, Calella, Barcelona, Centelles, L'Hospitalet de Llobregat
2023-10-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Barcelona, Pozuelo de Alarcón, Madrid, Málaga, Valencia
2023-07-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
537
Elche, Badalona, Barcelona, L'Hospitalet de Llobregat,Barcelona, Madrid, Málaga
2023-03-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Madrid, Málaga, Barcelona, Seville
2022-03-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Girona, Madrid, Valencia, Barcelona, Lugo, Málaga
2022-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Santander, Barcelona, Madrid, Málaga, Pamplona, Oviedo, Valencia
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Santander, Barcelona, Girona, Madrid, Málaga
2021-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Málaga, Seville
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Majadahonda, Pozuelo de Alarcón, Málaga, Barcelona, Seville, Valencia
2020-07-06
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/m-laga

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Málaga that also match the filters currently applied.

How many clinical trials are recruiting in Málaga?

16 of the 29 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Málaga), 29 studies
PhaseStudiesRecruitingShare
Phase 319765.5%
Phase 1/26620.7%
Phase 2216.9%
Phase 2/3226.9%

Most active sponsors

Lead sponsors with the most studies (Málaga)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2916
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.